OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mortality Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2023) Vol. 7, Iss. 5, pp. 499-513
Open Access | Times Cited: 28
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2023) Vol. 7, Iss. 5, pp. 499-513
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants
Daniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 10
Daniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 10
Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis
Massimo Franchini, Daniele Focosi, Mario Cruciani, et al.
Diseases (2024) Vol. 12, Iss. 3, pp. 41-41
Open Access | Times Cited: 8
Massimo Franchini, Daniele Focosi, Mario Cruciani, et al.
Diseases (2024) Vol. 12, Iss. 3, pp. 41-41
Open Access | Times Cited: 8
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 8
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 8
Convalescent plasma and predictors of mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis
Massimo Franchini, Mario Cruciani, Carlo Mengoli, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1514-1522
Closed Access | Times Cited: 7
Massimo Franchini, Mario Cruciani, Carlo Mengoli, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1514-1522
Closed Access | Times Cited: 7
Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial
Visa Nurmi, Richard Mayne, Chanice Knight, et al.
Journal of Infection (2025), pp. 106412-106412
Closed Access
Visa Nurmi, Richard Mayne, Chanice Knight, et al.
Journal of Infection (2025), pp. 106412-106412
Closed Access
Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma
Quigly Dragotakes, Patrick W. Johnson, Matthew R. Buras, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 41
Open Access | Times Cited: 4
Quigly Dragotakes, Patrick W. Johnson, Matthew R. Buras, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 41
Open Access | Times Cited: 4
Double-blinded, randomised, placebo-controlled trial of convalescent plasma for COVID-19: analyses by neutralising antibodies homologous to recipients’ variants
Tuba Khawaja, Mikael Kajova, Iris Levonen, et al.
Infectious Diseases (2024) Vol. 56, Iss. 6, pp. 423-433
Open Access | Times Cited: 3
Tuba Khawaja, Mikael Kajova, Iris Levonen, et al.
Infectious Diseases (2024) Vol. 56, Iss. 6, pp. 423-433
Open Access | Times Cited: 3
Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
Life (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 2
Massimo Franchini, Daniele Focosi
Life (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 2
Convalescent Plasma and the US Expanded Access Program: A Personal Narrative
Michael J. Joyner
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 2
Michael J. Joyner
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 2
Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients
Massimo Franchini, Arturo Casadevall, Jonathon W. Senefeld, et al.
Seminars in Thrombosis and Hemostasis (2023) Vol. 50, Iss. 04, pp. 648-653
Closed Access | Times Cited: 6
Massimo Franchini, Arturo Casadevall, Jonathon W. Senefeld, et al.
Seminars in Thrombosis and Hemostasis (2023) Vol. 50, Iss. 04, pp. 648-653
Closed Access | Times Cited: 6
Applying lessons of COVID-19 and other emerging infectious diseases to future outbreaks
Evan M. Bloch, David J. Sullivan, Arturo Casadevall, et al.
mBio (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 1
Evan M. Bloch, David J. Sullivan, Arturo Casadevall, et al.
mBio (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 1
Avoided and Avoidable Deaths with the Use of COVID-19 Convalescent Plasma in Italy during the First Two Years of Pandemic
Massimo Franchini, Arturo Casadevall, Quigly Dragotakes, et al.
Life (2024) Vol. 14, Iss. 9, pp. 1207-1207
Open Access | Times Cited: 1
Massimo Franchini, Arturo Casadevall, Quigly Dragotakes, et al.
Life (2024) Vol. 14, Iss. 9, pp. 1207-1207
Open Access | Times Cited: 1
The value of observational registry studies for the next infectious disease emergency
Jonathon W. Senefeld, Peter Marks, Arturo Casadevall, et al.
mBio (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 5
Jonathon W. Senefeld, Peter Marks, Arturo Casadevall, et al.
mBio (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 5
Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients
Massimo Franchini, Carlo Mengoli, Arturo Casadevall, et al.
Life (2024) Vol. 14, Iss. 7, pp. 792-792
Open Access | Times Cited: 1
Massimo Franchini, Carlo Mengoli, Arturo Casadevall, et al.
Life (2024) Vol. 14, Iss. 7, pp. 792-792
Open Access | Times Cited: 1
Considerations for the development of monoclonal antibodies to address new viral variants in COVID-19
Arturo Casadevall, Scott A. McConnell, Daniele Focosi
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 8, pp. 787-797
Closed Access | Times Cited: 1
Arturo Casadevall, Scott A. McConnell, Daniele Focosi
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 8, pp. 787-797
Closed Access | Times Cited: 1
Convalescent Plasma and Other Antibody Therapies for Infectious Diseases—Lessons Learned from COVID-19 and Future Prospects
David J. Sullivan
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
David J. Sullivan
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Avoided and avoidable deaths with the use of COVID-19 convalescent plasma in Italy during the first two years of pandemic
Massimo Franchini, Arturo Casadevall, Quigly Dragotakes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Massimo Franchini, Arturo Casadevall, Quigly Dragotakes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Evidence for the Efficacy of COVID-19 Convalescent Plasma
Stephen A. Klassen, Jonathon W. Senefeld
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Stephen A. Klassen, Jonathon W. Senefeld
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Misinterpretation of Clinical Research Findings and COVID-19 Mortality
Arturo Casadevall, Liise-anne Pirofski
Annals of Internal Medicine (2023) Vol. 176, Iss. 7, pp. 993-994
Open Access | Times Cited: 4
Arturo Casadevall, Liise-anne Pirofski
Annals of Internal Medicine (2023) Vol. 176, Iss. 7, pp. 993-994
Open Access | Times Cited: 4
Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters
Elise Wouters, Caro Verbrugghe, Rana Abdelnabi, et al.
EBioMedicine (2023) Vol. 92, pp. 104597-104597
Open Access | Times Cited: 4
Elise Wouters, Caro Verbrugghe, Rana Abdelnabi, et al.
EBioMedicine (2023) Vol. 92, pp. 104597-104597
Open Access | Times Cited: 4
Use of convalescent plasma in the treatment of COVID-19
Michael J. Joyner, Nigel Paneth, Arturo Casadevall
Nature Reviews Nephrology (2023) Vol. 19, Iss. 4, pp. 271-271
Open Access | Times Cited: 3
Michael J. Joyner, Nigel Paneth, Arturo Casadevall
Nature Reviews Nephrology (2023) Vol. 19, Iss. 4, pp. 271-271
Open Access | Times Cited: 3
Convalescent Plasma for Covid-19–Induced ARDS
Jonathon W. Senefeld, Jeffrey P. Henderson, Michael J. Joyner
New England Journal of Medicine (2024) Vol. 390, Iss. 4, pp. 384-386
Open Access
Jonathon W. Senefeld, Jeffrey P. Henderson, Michael J. Joyner
New England Journal of Medicine (2024) Vol. 390, Iss. 4, pp. 384-386
Open Access
Convalescent Plasma for Critically-ill Covid-19 Patients
Adel A. Aljatham, Waleed T. Hashim, Mohamad A. Almashiakhi, et al.
Research Square (Research Square) (2024)
Open Access
Adel A. Aljatham, Waleed T. Hashim, Mohamad A. Almashiakhi, et al.
Research Square (Research Square) (2024)
Open Access
Biochemical rationale for transfusion of high titre COVID-19 convalescent plasma
Caro Verbrugghe, Elise Wouters, Rosalie Devloo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Caro Verbrugghe, Elise Wouters, Rosalie Devloo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients
Carlo J. Iasella, S. Hannan, Emily J. Lyons, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0309449-e0309449
Open Access
Carlo J. Iasella, S. Hannan, Emily J. Lyons, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0309449-e0309449
Open Access
